Most recently, it has been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger https://williamd318xza0.anchor-blog.com/profile